BLEEDING, FVIII ACTIVITY, AND SAFETY 3 YEARS AFTER GENE TRANSFER WITH VALOCTOCOGENE ROXAPARVOVEC: RESULTS FROM GENER8-1

Autor: MC Ozelo, J Mahlangu, B Madan, J Mason, F Peyvandi, AV Drygalski, G Yamaguti-Hayakawa, TM Robinson, SW Pipe, TT Gener-Eigh

Publikováno v: Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S451-S452 (2023)

Aims: Valoctocogene roxaparvovec (AAV5-hFVIII-SQ) provides endogenous factor VIII (FVIII) production to prevent bleeding in people with severe hemophilia A. This study evaluated bleeding, FVIII activity and safety outcomes 3 years after receiving val

Externí odkaz: https://doaj.org/article/073f51b8f2be4bc78410d269a66d55b0

Attaining Poise: A Movement-based Lens Exploring Embodiment in Fashion

Autor: TM Robinson

Publikováno v: Fashion Theory. 23:441-458

This article makes a case for increased dialogue between the visual-, sensory-, and material-based methods currently available within social research and modes of socio-cultural enquiry typ...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::796246674eda0ccdf63c1d08f2b24723
https://doi.org/10.1080/1362704x.2019.1603876

Malignant mesenchymoma associated with an unusual vasoinvasive metastasis in a dog

Autor: JF McAnulty, RR Dubielzig, TM Robinson

Publikováno v: Journal of the American Animal Hospital Association. 34:295-299

A case of a malignant mesenchymoma with an unusual, vasoinvasive, metastatic behavior in a three-year-old, intact female basset hound is presented. Malignant mesenchymomas are rare neoplasms in humans and in dogs. No previous reports of a malignant m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f59e7b0679766d818da7bc964ef2f20
https://doi.org/10.5326/15473317-34-4-295

Synthetic Lethal Targeting of Cyclin Dependent Kinase-12-Deficient Prostate Cancer with PARP Inhibitors.

Autor: Chou J; University of California, San Francisco, San Francisco, CA, United States., Robinson TM; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Egusa EA; University of California, San Francisco, San Francisco, CA, United States., Lodha R; Cleveland Clinic Lerner College of Medicine, Cleveland, OH, United States., Zhang M; University of California, San Francisco, San Francisco, United States., Badura M; University of California, San Francisco, San Francisco, CA, United States., Mikayelyan M; University of California, San Francisco, San Francisco, CA, United States., Delavan H; University of California, San Francisco, San Francisco, CA, United States., Swinderman J; University of California, San Francisco, San Francisco, CA, United States., Wilson C; University of California, San Francisco, San Francisco, ca, United States., Zhu J; University of California, San Francisco, San Francisco, CA, United States., Das R; University Hospitals of Cleveland, Cleveland, OH, United States., Nguyen M; Clovis Oncology, Inc., San Francisco, CA, United States., Loehr A; Clovis Oncology (United States), Boulder, United States., Golsorkhi T; Clovis Oncology (United States), San Francisco, California, United States., Simmons A; Clovis Oncology, Inc., San Francisco, CA, United States., Abida W; Memorial Sloan Kettering Cancer Center, New York, NY, United States., Chinnaiyan AM; University of Michigan-Ann Arbor, Ann Arbor, MI, United States., Arkin MR; University of California, San Francisco, San Francisco, ca, United States., Small EJ; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, United States., Quigley DA; University of California, San Francisco, San Francisco, CA, United States., Yang L; University of Chicago, United States., Kim M; The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States., Ashworth A; University of California, San Francisco, San Francisco, CA, United States., Feng FY; University of California, San Francisco, San Francisco, CA, United States.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 25. Date of Electronic Publication: 2024 Sep 25.

On-Demand Bioactivation of Inert Materials With Plasma-Polymerized Nanoparticles.

Autor: Santos M; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia., Michael PL; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia., Mitchell TC; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia., Lam YT; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia., Robinson TM; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia., Moore MJ; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia., Tan RP; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia., Rnjak-Kovacina J; Graduate School of Biomedical Engineering, University of New South Wales, Sydney, New South Wales, 2006, Australia., Lim KS; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia., Wise SG; School of Medical Sciences, University of Sydney, Sydney, New South Wales, 2006, Australia.

Publikováno v: Advanced materials (Deerfield Beach, Fla.) [Adv Mater] 2024 Sep; Vol. 36 (38), pp. e2311313. Date of Electronic Publication: 2024 Mar 20.